Author

J. K. Fleming

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Organism:virus· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. Samadi· 1 shared C. Okumura· 1 shared K. C. Entzminger· 1 shared L. Y. Espinosa· 1 shared P. D. Entzminger· 1 shared T. Maruyama· 1 shared Y. Hiramoto· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Samadi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Rapid engineering of SARS-CoV-2 therapeutic antibodies to increase breadth of neutralization including XBB.1.5 and BQ.1.1

K. C. Entzminger, J. K. Fleming, P. D. Entzminger, L. Y. Espinosa, A. Samadi, Y. Hiramoto, C. Okumura, T. Maruyama

This study engineers broadly neutralizing antibodies against SARS-CoV-2 variants using phage display and STEM technology, resulting in mAbs effective against XBB.1.5 and BQ.1.1.

bioRxiv · Jan 25, 2023 · PreprintImmunology